Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
Apply
Obrixtamig & Chemotherapy
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step